N-[[(5S)-3-[4-[2-[(3S,4S)-3,4-dihydroxypiperidin-4-yl]ethoxy]-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3-hydroxypyrrolidin-3-yl)methoxy]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3S,4S)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-(2-piperazin-1-ylethoxy)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide

C71H95F4N13O20 — CID 160589278

About N-[[(5S)-3-[4-[2-[(3S,4S)-3,4-dihydroxypiperidin-4-yl]ethoxy]-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3-hydroxypyrrolidin-3-yl)methoxy]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3S,4S)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-(2-piperazin-1-ylethoxy)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide

N-[[(5S)-3-[4-[2-[(3S,4S)-3,4-dihydroxypiperidin-4-yl]ethoxy]-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3-hydroxypyrrolidin-3-yl)methoxy]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3S,4S)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-(2-piperazin-1-ylethoxy)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide (PubChem CID 160589278) has the molecular formula C71H95F4N13O20 and a molecular weight of 1526.60 g/mol. Its IUPAC name is N-[[(5S)-3-[4-[2-[(3S,4S)-3,4-dihydroxypiperidin-4-yl]ethoxy]-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3-hydroxypyrrolidin-3-yl)methoxy]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3S,4S)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-(2-piperazin-1-ylethoxy)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide.

Molecular Properties

• Compound Name: N-[[(5S)-3-[4-[2-[(3S,4S)-3,4-dihydroxypiperidin-4-yl]ethoxy]-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3-hydroxypyrrolidin-3-yl)methoxy]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3S,4S)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-(2-piperazin-1-ylethoxy)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
• PubChem CID: 160589278
• Molecular Formula: C71H95F4N13O20
• Molecular Weight: 1526.60 g/mol
• Exact Mass: 1525.68
• IUPAC Name: N-[[(5S)-3-[4-[2-[(3S,4S)-3,4-dihydroxypiperidin-4-yl]ethoxy]-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3-hydroxypyrrolidin-3-yl)methoxy]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3S,4S)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-(2-piperazin-1-ylethoxy)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
• SMILES: CC(=O)NC[C@H]1CN(c2ccc(OCC3(O)CCNC3)c(F)c2)C(=O)O1.CC(=O)NC[C@H]1CN(c2ccc(OCCN3CCNCC3)c(F)c2)C(=O)O1.CC(=O)NC[C@H]1CN(c2ccc(OCC[C@@]3(O)CCNC[C@@H]3O)c(F)c2)C(=O)O1.CO[C@H]1CNC[C@@H]1Oc1ccc(N2C[C@H](CNC(C)=O)OC2=O)cc1F
• InChI: InChI=1S/C19H26FN3O6.C18H25FN4O4.2C17H22FN3O5/c1-12(24)22-9-14-11-23(18(26)29-14)13-2-3-16(15(20)8-13)28-7-5-19(27)4-6-21-10-17(19)25;1-13(24)21-11-15-12-23(18(25)27-15)14-2-3-17(16(19)10-14)26-9-8-22-6-4-20-5-7-22;1-10(22)20-6-12-9-21(17(23)25-12)11-3-4-14(13(18)5-11)26-16-8-19-7-15(16)24-2;1-11(22)20-7-13-8-21(16(23)26-13)12-2-3-15(14(18)6-12)25-10-17(24)4-5-19-9-17/h2-3,8,14,17,21,25,27H,4-7,9-11H2,1H3,(H,22,24);2-3,10,15,20H,4-9,11-12H2,1H3,(H,21,24);3-5,12,15-16,19H,6-9H2,1-2H3,(H,20,22);2-3,6,13,19,24H,4-5,7-10H2,1H3,(H,20,22)/t14-,17-,19-;15-;12-,15-,16-;13-,17?/m0000/s1
• InChIKey: RCUIDSBBOXSUHE-CSLGVQJXSA-N
• XLogP: 1.75
• TPSA: 392.76 Ų
• H-Bond Donors: 11
• H-Bond Acceptors: 25
• Rotatable Bonds: 26
• Heavy Atoms: 108
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	1526.60
LogP ≤ 5	1.75
H-Bond Donors ≤ 5	11
H-Bond Acceptors ≤ 10	25

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of N-[[(5S)-3-[4-[2-[(3S,4S)-3,4-dihydroxypiperidin-4-yl]ethoxy]-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3-hydroxypyrrolidin-3-yl)methoxy]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3S,4S)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-(2-piperazin-1-ylethoxy)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide?

The IUPAC name of N-[[(5S)-3-[4-[2-[(3S,4S)-3,4-dihydroxypiperidin-4-yl]ethoxy]-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3-hydroxypyrrolidin-3-yl)methoxy]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3S,4S)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-(2-piperazin-1-ylethoxy)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide (CID 160589278) is N-[[(5S)-3-[4-[2-[(3S,4S)-3,4-dihydroxypiperidin-4-yl]ethoxy]-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3-hydroxypyrrolidin-3-yl)methoxy]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3S,4S)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-(2-piperazin-1-ylethoxy)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide.

What is the SMILES notation for N-[[(5S)-3-[4-[2-[(3S,4S)-3,4-dihydroxypiperidin-4-yl]ethoxy]-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3-hydroxypyrrolidin-3-yl)methoxy]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3S,4S)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-(2-piperazin-1-ylethoxy)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide?

The canonical SMILES for N-[[(5S)-3-[4-[2-[(3S,4S)-3,4-dihydroxypiperidin-4-yl]ethoxy]-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3-hydroxypyrrolidin-3-yl)methoxy]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3S,4S)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-(2-piperazin-1-ylethoxy)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide is CC(=O)NC[C@H]1CN(c2ccc(OCC3(O)CCNC3)c(F)c2)C(=O)O1.CC(=O)NC[C@H]1CN(c2ccc(OCCN3CCNCC3)c(F)c2)C(=O)O1.CC(=O)NC[C@H]1CN(c2ccc(OCC[C@@]3(O)CCNC[C@@H]3O)c(F)c2)C(=O)O1.CO[C@H]1CNC[C@@H]1Oc1ccc(N2C[C@H](CNC(C)=O)OC2=O)cc1F.

What is the InChIKey of N-[[(5S)-3-[4-[2-[(3S,4S)-3,4-dihydroxypiperidin-4-yl]ethoxy]-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3-hydroxypyrrolidin-3-yl)methoxy]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3S,4S)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-(2-piperazin-1-ylethoxy)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide?

The InChIKey is RCUIDSBBOXSUHE-CSLGVQJXSA-N. The full InChI is InChI=1S/C19H26FN3O6.C18H25FN4O4.2C17H22FN3O5/c1-12(24)22-9-14-11-23(18(26)29-14)13-2-3-16(15(20)8-13)28-7-5-19(27)4-6-21-10-17(19)25;1-13(24)21-11-15-12-23(18(25)27-15)14-2-3-17(16(19)10-14)26-9-8-22-6-4-20-5-7-22;1-10(22)20-6-12-9-21(17(23)25-12)11-3-4-14(13(18)5-11)26-16-8-19-7-15(16)24-2;1-11(22)20-7-13-8-21(16(23)26-13)12-2-3-15(14(18)6-12)25-10-17(24)4-5-19-9-17/h2-3,8,14,17,21,25,27H,4-7,9-11H2,1H3,(H,22,24);2-3,10,15,20H,4-9,11-12H2,1H3,(H,21,24);3-5,12,15-16,19H,6-9H2,1-2H3,(H,20,22);2-3,6,13,19,24H,4-5,7-10H2,1H3,(H,20,22)/t14-,17-,19-;15-;12-,15-,16-;13-,17?/m0000/s1.

What are the key properties of N-[[(5S)-3-[4-[2-[(3S,4S)-3,4-dihydroxypiperidin-4-yl]ethoxy]-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3-hydroxypyrrolidin-3-yl)methoxy]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3S,4S)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-(2-piperazin-1-ylethoxy)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide?

N-[[(5S)-3-[4-[2-[(3S,4S)-3,4-dihydroxypiperidin-4-yl]ethoxy]-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3-hydroxypyrrolidin-3-yl)methoxy]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3S,4S)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-(2-piperazin-1-ylethoxy)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide has a molecular weight of 1526.60 g/mol, XLogP of 1.75, 26 rotatable bonds, 11 hydrogen bond donors, and 25 hydrogen bond acceptors.

Where does this data come from?

All data for N-[[(5S)-3-[4-[2-[(3S,4S)-3,4-dihydroxypiperidin-4-yl]ethoxy]-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3-hydroxypyrrolidin-3-yl)methoxy]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-[(3S,4S)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-[3-fluoro-4-(2-piperazin-1-ylethoxy)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide is sourced from PubChem (CID 160589278), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).